Edition:
United Kingdom

AnaptysBio Inc (ANAB.OQ)

ANAB.OQ on NASDAQ Stock Exchange Global Select Market

49.20USD
16 Aug 2019
Change (% chg)

$-0.79 (-1.58%)
Prev Close
$49.99
Open
$50.07
Day's High
$50.76
Day's Low
$48.69
Volume
100,938
Avg. Vol
96,294
52-wk High
$110.00
52-wk Low
$46.55

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.08 December 17 Aug 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 4 4
(2) OUTPERFORM 4 4 6 6
(3) HOLD 3 3 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 1.73 1.73

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 10 2.80 10.00 0.00 1.50
Quarter Ending Dec-19 10 2.80 10.00 0.00 1.50
Year Ending Dec-19 10 8.60 25.00 0.00 4.33
Year Ending Dec-20 10 10.73 41.00 0.00 9.23
Earnings (per share)
Quarter Ending Sep-19 9 -1.08 -0.77 -1.34 --
Quarter Ending Dec-19 9 -1.19 -0.77 -1.53 --
Year Ending Dec-19 10 -4.12 -3.50 -5.10 -3.85
Year Ending Dec-20 10 -5.12 -4.43 -6.03 -4.21

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-19 0.00 5.00 5.00 0.00
Quarter Ending Mar-19 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 1.17 0.00 1.17 100.00
Quarter Ending Sep-18 0.25 5.00 4.75 1,900.00
Quarter Ending Jun-18 0.65 0.00 0.65 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 2.80 3.80 3.80 3.80 1.50
Quarter Ending Dec-19 2.80 2.80 2.80 2.80 1.50
Year Ending Dec-19 8.60 6.60 6.60 6.60 4.33
Year Ending Dec-20 10.73 10.73 10.73 10.73 9.23

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 2 0 2
Quarter Ending Dec-19 0 0 0 0
Year Ending Dec-19 4 0 4 0
Year Ending Dec-20 0 0 0 0
Earnings